Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 23, 2020
A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North AfricaMuhamed-Kheir Taha, Jessica Presa, Lidia SerraVaccine|May 12, 2020
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studiesChris Webber, Paula Peyrani, Paul Balmer, et al.Infectious Diseases and Therapy|April 4, 2020
Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the LiteratureLidia Serra, Jessica Presa, Hannah Christensen, et al.Expert Review of Vaccines|April 7, 2020
Protecting the most vulnerable age group: a review of MenACWY-TT immunogenicity and safety in infantsFederico Martinón-Torres, Lidia Serra, Marco Aurelio P SafadiHuman Vaccines & Immunotherapeutics|March 23, 2018
Impact of meningococcal vaccination on carriage and disease transmission: A review of the literaturePaul Balmer, Cynthia Burman, Lidia Serra, et al.Human Vaccines & Immunotherapeutics|April 28, 2022
Preventing invasive meningococcal disease in early infancyJessica Presa, Lidia Serra, Catherine Weil-Olivier, et al.Infectious Diseases and Therapy|July 27, 2019
Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A ReviewJessica Presa, Jamie Findlow, Jelena Vojicic, et al.Human Vaccines & Immunotherapeutics|February 19, 2021
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccinesLidia Serra, Markus Knuf, Federico Martinón-Torres, et al.Vaccine|October 25, 2022
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccineLidia Serra, Chris Webber, Cindy Burman, et al.Human Vaccines & Immunotherapeutics|October 2, 2018
Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccinationCynthia Burman, Lidia Serra, Charles Nuttens, et al.Pageof 2